Graham, David J.

Incidence of hospitalized rhabdomyolysis in patients treated with lipid-lowering drugs

Graham, D. J. (2004) · JAMA

Lipoproteins and Cardiovascular HealthMuscle and Compartmental Disorders

Cited by 875

Cardiovascular, bleeding, and mortality risks in elderly medicare patients treated with dabigatran or warfarin for nonvalvular atrial fibrillation

Graham, D. J., Reichman, M. E., Wernecke, M., Zhang, R., Southworth, M. R., Levenson, M., Sheu, T.-C., Mott, K., Goulding, M. R., Houstoun, M., et al. (2015) · Circulation

Atrial Fibrillation Management and OutcomesVenous Thromboembolism Diagnosis and Management

Cited by 644

Comparative risk of anaphylactic reactions associated With intravenous iron products

Wang, C., Graham, D. J., Kane, R. C., Xie, D., Wernecke, M., Levenson, M., MaCurdy, T. E., Houstoun, M., Ryan, Q., Wong, S., et al. (2015) · JAMA

Drug-Induced Adverse ReactionsFood Allergy and Anaphylaxis Research

Cited by 219

Cardiovascular Risk in Rheumatoid Arthritis: Comparing TNF-α Blockade with Nonbiologic DMARDs

Solomon, D. H., Curtis, J. R., Saag, K. G., Lii, J., Chen, L., Harrold, L. R., Herrinton, L. J., Graham, D. J., Kowal, M. K., Kuriya, B., et al. (2013) · The American Journal of Medicine

Rheumatoid Arthritis Research and TherapiesAutoimmune and Inflammatory Disorders Research

Cited by 111

Severe hypoglycemia risk with long-acting insulin analogs vs neutral protamine Hagedorn insulin

Bradley, M. C., Chillarige, Y., Lee, H., Wu, X., Parulekar, S., Muthuri, S., Wernecke, M., MaCurdy, T. E., Kelman, J. A., & Graham, D. J. (2021) · JAMA Internal Medicine

Diabetes Management and ResearchDiabetes Treatment and Management

Cited by 45

Mortality among Parkinson's disease patients treated with pimavanserin or atypical antipsychotics: an observational study in Medicare beneficiaries

Mosholder, A. D., Ma, Y., Akhtar, S., Podskalny, G. D., Feng, Y., Lyu, H., Liao, J., Wei, Y., Wernecke, M., Leishear, K., et al. (2022) · American Journal of Psychiatry

Parkinson's Disease Mechanisms and TreatmentsSchizophrenia research and treatment

Cited by 33

Association between generic-to-generic levothyroxine switching and thyrotropin levels among US adults.

Brito, J. P., Deng, Y., Ross, J. S., Choi, N. H., Graham, D. J., Qiang, Y., Rantou, E., Wang, Z., Zhao, L., Shah, N. D., et al. (2022) · JAMA Internal Medicine

Thyroid Disorders and TreatmentsPharmaceutical Economics and Policy

Cited by 29

Comparative effectiveness of generic vs brand-name levothyroxine in achieving normal thyrotropin levels.

Brito, J. P., Ross, J. S., Sangaralingham, L., Dutcher, S. K., Graham, D. J., Wang, Z., Wu, Y., Yao, X., Smallridge, R. C., Bernet, V., et al. (2020) · JAMA Network Open

Thyroid Disorders and TreatmentsPharmaceutical Economics and Policy

Cited by 28

Rates of, and factors associated with, switching among generic levothyroxine preparations in commercially insured American adults

Brito, J. P., Deng, Y., Ross, J. S., Choi, N. H., Graham, D. J., Qiang, Y., Rantou, E., Wang, Z., Zhao, L., Shah, N. D., et al. (2022) · Endocrine

Pharmaceutical Economics and PolicyThyroid Disorders and Treatments

Cited by 4